MSTN and cardiomyopathy: Muscle growth resulting from myostatin inactivation presumably creates an imbalance between the metabolic requirements of tissue cells and the previous perfusion capabilities of blood vessels, and CSRP3-encoded MLP may work to mediate this stress and reduce likelihood of cardiomyopathy.